Towards Evidence-Based Management of Inherited Breast and Breast-Ovarian Cancer

ανά Møller Pål
Έκδοση 2004-12-01

Towards Evidence-Based Management of Inherited Breast and Breast-Ovarian Cancer

ανά Møller, Pål
Έκδοση 2004

The Prospective Lynch Syndrome Database reports enable evidence-based personal precision health care

ανά Møller, Pål
Τόπος έκδοσης Hered Cancer Clin Pract (2020)

The BRCA2 variant c.68-7 T>A is associated with breast cancer

ανά Møller, Pål, Hovig, Eivind
Τόπος έκδοσης Hered Cancer Clin Pract (2017)

Retraction Note to: The BRCA2 variant c.68–7 T > A is associated with breast cancer

ανά Møller, Pål, Hovig, Eivind
Τόπος έκδοσης Hered Cancer Clin Pract (2018)

Our genes, our selves: hereditary breast cancer and biological citizenship in Norway

ανά Møller, Pål, Hovig, Eivind
Τόπος έκδοσης Med Health Care Philos (2017)

Costs and Benefits of Diagnosing Familial Breast Cancer

ανά Heimdal, Ketil, Mæhle, Lovise, Møller, Pål
Έκδοση 1999

MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis

ανά Tharmaratnam, Kukatharmini, Hagen, Anne Irene, Møller, Pål
Τόπος έκδοσης Breast Cancer Res Treat (2014)

No Sib Pair Concordance for Breast or Ovarian Cancer in BRCA1 Mutation Carriers

ανά Møller, Pål, Mæhle, Lovise, Clark, Neal, Apold, Jaran
Έκδοση 2007

Uptake of Genetic Testing and Pre-Test Levels of Mental Distress in Norwegian Families with Known BRCA1 Mutations

ανά Reichelt, Jon G., Dahl, Alv A., Heimdal, Ketil, Møller, Pål
Έκδοση 1999

Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift

ανά Møller, Pål, Dominguez-Valentin, Mev, Rødland, Einar Andreas, Hovig, Eivind
Τόπος έκδοσης Cancers (Basel) (2019)

Correction: Møller, P.; et al. Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift. Cancers 2019, 11...

ανά Møller, Pål, Dominguez-Valentin, Mev, Rødland, Einar Andreas, Hovig, Eivind
Τόπος έκδοσης Cancers (Basel) (2020)

Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)

ανά Seppälä, Toni T., Dominguez-Valentin, Mev, Sampson, Julian R., Møller, Pål
Τόπος έκδοσης Fam Cancer (2020)

MUTYH Mutations Do Not Cause HNPCC or Late Onset Familial Colorectal Cancer

ανά Stormorken, Astrid, Heintz, Karen-Marie, Andresen, Per Arne, Hovig, Eivind, Møller, Pål
Έκδοση 2006

BRCA1 1675delA and 1135insA Account for One Third of Norwegian Familial Breast-Ovarian Cancer and Are Associated with Later Disease Onset than Less Frequent Mutations

ανά Borg, Åke, Dørum, Anne, Heimdal, Ketil, Mæhle, Lovise, Hovig, Eivind, Møller, Pål
Έκδοση 1999

Survival in Norwegian BRCA1 mutation carriers with breast cancer

ανά Hagen, Anne Irene, Tretli, Steinar, Mæhle, Lovise, Apold, Jaran, Vedå, Nina, Møller, Pål
Έκδοση 2009

Ten modifiers of BRCA1 penetrance validated in a Norwegian series

ανά Heramb, Cecilie, Ekstrøm, Per Olaf, Tharmaratnam, Kukatharmini, Hovig, Eivind, Møller, Pål, Mæhle, Lovise
Τόπος έκδοσης Hered Cancer Clin Pract (2015)

Germline PTEN mutations are rare and highly penetrant

ανά Rustad Cecilie F, Bjørnslett Merete, Heimdal Ketil R, Mæhle Lovise, Apold Jaran, Møller Pål
Έκδοση 2006-12-01

Germline PTEN mutations are rare and highly penetrant

ανά Rustad, Cecilie F, Bjørnslett, Merete, Heimdal, Ketil R, Mæhle, Lovise, Apold, Jaran, Møller, Pål
Έκδοση 2006

The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation

ανά Møller, Pål, Stormorken, Astrid, Holmen, Marit Muri, Hagen, Anne Irene, Vabø, Anita, Mæhle, Lovise
Έκδοση 2014